| Regulation of E2Fs and senescence by PML nuclear bodies M Vernier, V Bourdeau, MF Gaumont-Leclerc, O Moiseeva, V Bégin, ... Genes & development 25 (1), 41-50, 2011 | 183 | 2011 |
| The sodium pump α1 sub‐unit: a disease progression–related target for metastatic melanoma treatment V Mathieu, C Pirker, E Martin de Lassalle, M Vernier, T Mijatovic, ... Journal of cellular and molecular medicine 13 (9b), 3960-3972, 2009 | 137 | 2009 |
| Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer É Audet-Walsh, CR Dufour, T Yee, FZ Zouanat, M Yan, G Kalloghlian, ... Genes & development 31 (12), 1228-1242, 2017 | 125 | 2017 |
| SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes E Saint-Germain, L Mignacca, M Vernier, D Bobbala, S Ilangumaran, ... Aging (Albany NY) 9 (10), 2137, 2017 | 92 | 2017 |
| Androgen-dependent repression of ERRγ reprograms metabolism in prostate cancer É Audet-Walsh, T Yee, S McGuirk, M Vernier, C Ouellet, J St-Pierre, ... Cancer research 77 (2), 378-389, 2017 | 84 | 2017 |
| Estrogen-related receptors are targetable ROS sensors M Vernier, CR Dufour, S McGuirk, C Scholtes, X Li, G Bourmeau, ... Genes & Development 34 (7-8), 544-559, 2020 | 78 | 2020 |
| SREBF1 activity is regulated by an AR/mTOR nuclear axis in prostate cancer É Audet-Walsh, M Vernier, T Yee, C Laflamme, S Li, Y Chen, V Giguère Molecular Cancer Research 16 (9), 1396-1405, 2018 | 71 | 2018 |
| A CDK4/6-dependent epigenetic mechanism protects cancer cells from PML-induced senescence M Acevedo, M Vernier, L Mignacca, F Lessard, G Huot, O Moiseeva, ... Cancer research 76 (11), 3252-3264, 2016 | 56 | 2016 |
| Deficiency of interleukin-15 confers resistance to obesity by diminishing inflammation and enhancing the thermogenic function of adipose tissues G Lacraz, V Rakotoarivelo, SM Labbé, M Vernier, C Noll, M Mayhue, ... PLoS One 11 (9), e0162995, 2016 | 44 | 2016 |
| Retinoblastoma‐independent regulation of cell proliferation and senescence by the p53–p21 axis in lamin A/C‐depleted cells O Moiseeva, V Bourdeau, M Vernier, MC Dabauvalle, G Ferbeyre Aging Cell 10 (5), 789-797, 2011 | 40 | 2011 |
| Resistance to different anthracycline chemotherapeutics elicits distinct and actionable primary metabolic dependencies in breast cancer S McGuirk, Y Audet-Delage, MG Annis, Y Xue, M Vernier, K Zhao, ... Elife 10, e65150, 2021 | 35 | 2021 |
| CHES1/FOXN3 regulates cell proliferation by repressing PIM2 and protein biosynthesis G Huot, M Vernier, V Bourdeau, L Doucet, E Saint-Germain, ... Molecular biology of the cell 25 (5), 554-565, 2014 | 34 | 2014 |
| Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4 M Vernier, S McGuirk, CR Dufour, L Wan, E Audet-Walsh, J St-Pierre, ... Oncogene 39 (41), 6406-6420, 2020 | 31 | 2020 |
| Aging, senescence and mitochondria: the PGC-1/ERR axis M Vernier, V Giguère Journal of Molecular Endocrinology 66 (1), R1-R14, 2021 | 30 | 2021 |
| Mutant lamin A links prophase to a p53 independent senescence program O Moiseeva, F Lessard, M Acevedo-Aquino, M Vernier, YS Tsantrizos, ... Cell cycle 14 (15), 2408-2421, 2015 | 26 | 2015 |
| Complete senescence: RB and PML share the task M Vernier, G Ferbeyre Cell Cycle 13 (5), 696-696, 2014 | 18 | 2014 |
| Regulation and role of calcium in cellular senescence N Martin, K Zhu, J Czarnecka-Herok, M Vernier, D Bernard Cell Calcium 110, 102701, 2023 | 15 | 2023 |
| Targeting chemoresistant senescent pancreatic cancer cells improves conventional treatment efficacy S Jaber, M Warnier, C Leers, M Vernier, D Goehrig, JJ Médard, ... Molecular Biomedicine 4 (1), 4, 2023 | 12 | 2023 |
| The mTOR chromatin-bound interactome in prostate cancer CR Dufour, C Scholtes, M Yan, Y Chen, L Han, T Li, H Xia, Q Deng, ... Cell Reports 38 (12), 2022 | 9 | 2022 |
| Cholesterol biosynthetic pathway induces cellular senescence through ERRα DV Ziegler, J Czarnecka-Herok, M Vernier, C Scholtes, C Camprubi, ... npj Aging 10 (1), 5, 2024 | 2 | 2024 |
